Middle East Veterinary Vaccines Market

Middle East Veterinary Vaccines Market Size, Market Forecast and Outlook By FMI

Middle East veterinary vaccines market is expected to expand from USD 678.3 million in 2025 to USD 1,053.3 million by 2035. The market is anticipated to register 4.0% CAGR during the forecast period. Live attenuated vaccines are likely to lead with 45% share, while veterinary hospitals are projected to account for 42% of end user share in 2025.

Summary of the Middle East Veterinary Vaccines Market

• Demand and Growth Drivers
  • Animal health programs are raising vaccine use across livestock and poultry farms.
  • Zoonotic disease control is increasing the need for planned vaccination programs.
  • Pet ownership in urban centers is widening companion animal vaccine demand.
• Product and Segment View
  • Live attenuated vaccines remain preferred due to strong immune response.
  • Veterinary hospitals lead end use due to diagnosis and preventive care capacity.
  • Poultry and livestock vaccines keep demand steady across food supply networks.
• Geography and Competitive Outlook
  • UAE benefits from advanced veterinary care and strong equine health demand.
  • Saudi Arabia gains from animal welfare programs and larger livestock management needs.
  • Zoetis, Merck Animal Health, Boehringer Ingelheim, and Ceva Santé Animale remain key suppliers.
• Analyst Opinion
  • Sabyasachi Ghosh, Principal Analyst for Healthcare at FMI, opines, “Veterinary vaccine demand in the Middle East is moving toward wider preventive coverage across livestock, poultry, and companion animals. Local production, better cold chain systems, and stronger disease surveillance will decide how quickly vaccine access improves across both urban and rural markets.”
• Middle East Veterinary Vaccines Market Value Analysis
  • Regional demand is moving from outbreak response toward planned immunization programs.
  • Livestock producers need vaccines to protect herd productivity and food supply stability.
  • Companion animal care is creating new demand across urban veterinary hospitals.
  • Local manufacturing can reduce import reliance and improve outbreak response speed.

Attribute	Value
Market Size in 2025	USD 678.3 million
Market Size in 2035	USD 1,053.3 million
CAGR (2025 to 2035)	4%

Analyzing Middle East Veterinary Vaccines Market by Top Investment Segments

The middle east veterinary vaccines market is expected to experience steady growth, driven by key segments such as live attenuated vaccines and veterinary hospitals as the leading end user. Live attenuated vaccines are projected to dominate the market, while veterinary hospitals will continue to lead the adoption of veterinary vaccines for animal healthcare.

Live Attenuated Vaccines to Capture 45% of the Veterinary Vaccines Market Share

Live attenuated vaccines are expected to capture 45% of the Middle East veterinary vaccines market share by 2025. These vaccines, which contain live pathogens that have been weakened but are still capable of inducing an immune response, are widely used in veterinary practices due to their effectiveness in providing long-lasting immunity.

Live attenuated vaccines are commonly used to prevent diseases in animals such as rabies, foot-and-mouth disease, and avian influenza. Companies like Zoetis, Merck Animal Health, and Bayer Animal Health are key players in the development and distribution of these vaccines.

Live attenuated vaccines are favored in both small and large animal care for their proven efficacy in disease prevention and relatively low cost. As the demand for improved animal health, particularly in livestock and poultry, continues to rise in the Middle East, live attenuated vaccines are expected to remain the preferred choice for disease prevention, making them the dominant segment in the veterinary vaccines market.

Veterinary Hospitals to Capture 42% of the Veterinary Vaccines Market Share

Veterinary hospitals are projected to account for 42% of the veterinary vaccines market share in the Middle East by 2025. These hospitals are major consumers of veterinary vaccines, as they play a critical role in diagnosing and treating animal diseases, as well as in preventive care through vaccination.

The rising demand for pet healthcare, alongside the growing livestock and poultry industries in the region, is driving the need for veterinary vaccines. Veterinary hospitals are increasingly adopting advanced vaccines, including live attenuated and inactivated vaccines, to improve animal health and control the spread of diseases.

Companies such as Elanco, Vetoquinol, and Virbac are working with veterinary hospitals to provide vaccines and other healthcare products for animals. As veterinary care continues to advance, with increasing focus on both companion animals and livestock, veterinary hospitals will remain a key end user in the market, driving the continued demand for vaccines and improving overall animal health outcomes across the region.

Challenges and Opportunities

A Lack of Trained Veterinarians Impacts the Effective Administration of Vaccines and Disease Management Programs.

The various challenges being faced by the Middle East veterinary vaccine industry are structural and operational. Various regulatory environments for different countries prevent vaccines from being timely approved and harmonized, limiting their cross-border distribution and trade. Other focused issues include poor standards in cold chain logistics, which affect vaccine stability and efficacy, particularly in remote or rural situations. Many areas also have shortages of trained veterinary professionals, which also affects vaccine administration and monitoring.

Even with government and donor efforts, vaccines remain unaffordable to most in low-income and conflict-affected areas. On top of that, smallholder farmers sometimes hesitate to vaccinate animals due to a lack of knowledge about the vaccines, perceived costs, or mistrust of government programs. In addition, it limits tracking and response capabilities in real time because of the absence of consolidated animal disease surveillance networks.

Expansion of Veterinary Clinics in Major Cities Strengthens the Availability of Vaccines and Advanced Veterinary Treatment Options.

Though there are challenges, the Middle East veterinary vaccine market is creating many opportunities that can quicken growth in this area. The growing trend of regional manufacturing of vaccines, particularly in the Gulf Cooperation Council (GCC), as governments look at pharmaceutical sovereignty by reducing dependency on imports, is a critical opportunity through which they can bring down prices, accelerate distribution, and improve response during outbreaks.

Urbanization, as well as rising disposable income, is a growing niche for pet ownership that is demanding increasing scopes of companion animal mammalian vaccines for diseases such as rabies and canine distemper. Further, awareness of zoonotic diseases has increased post-COVID-19, which has galvanized support for One Health initiatives combining human, animal, and environmental health strategies.

Such frameworks would provide suitable platforms upon which to expand veterinary vaccination programs and gather multi-sectoral funding. The increasing embrace of digital health tools, one such example being mobile-based applications for livestock management and vaccination reminder enhancement, is promoting better adherence and farmer engagement.

Industry-Specific Highlights

Poultry Vaccine Demand

The poultry sector represents the most dynamic component of the veterinary vaccine market in the Middle East. Poultry meat and eggs form a significant part of the regional diet, and countries such as Saudi Arabia, Egypt, and Iran are among the largest producers in the region. Diseases like Newcastle disease, infectious bronchitis, avian influenza, and Marek’s disease are endemic threats that prompt consistent vaccination protocols.

Layer and broiler farms, particularly in the GCC, operate on intensive farming models that rely on strict biosecurity and scheduled immunization. The rise of vertically integrated poultry businesses has improved compliance with best practices and facilitated the adoption of thermostable and multivalent vaccines. Moreover, demand is shifting toward recombinant and vector-based poultry vaccines that offer improved protection and administration convenience.

Emerging Trends

Emerging Zoonotic Threats

The presence of zoonotic diseases like the Middle East Respiratory Syndrome Coronavirus (MERS-CoV), Rift Valley fever, and brucellosis has made the case for considerable veterinary vaccination systems across the Middle East more imminent. The underlying diseases interfere with livestock productivity and also possess direct public health threats to some measure, and hence they have an area of concern globally.

One Health is a paradigm that recognizes the interrelationship among human health, animal health, and environmental health, and this has become a unifying science behind vaccine-oriented surveillance and control programs. Hence, governments are now including veterinary immunization within the frameworks of epidemic preparedness plans. For instance, vaccine campaigns for Rift Valley fever are being coordinated with vector control and restrictions on livestock movements.

Brief Market Overview

As the rising needs of livestock products, growing awareness for the health of animals, and governmental initiatives for improvement of veterinary healthcare structure have matured well to trigger a steady growth for the veterinary vaccine industry in Middle East countries between 2020 to 2024, which is approximately valued at USD 652.2 million in 2024 and projected to exceed USD 1,053.3 million by 2035, it translates to a compound-anonal growth rate (CAGR) of about 4% for the forecast period.

The key factors propelling this growth include region-specific vaccines for diseases targeting camels and collaborative programs for disease control in line with regional standards.

Country-Wise Analysis

United Arab Emirates

Market Outlook

The Veterinary Vaccines market in the UAE is primarily driven by the strong horse racing culture and elite endurance riding events that the country has to offer in addition to robust government support for sport. The country is known for maximum investments in sophisticated equine medical care, owning expensive stables, hiring specialized veterinary hospitals, etc., focusing on the best treatments.

This increased activity, in conjunction with international equestrian events such as the Dubai World Cup, drives the demand for regenerative medicine, joint health solutions and performance-enhancing therapeutics. Rich owners propel the adoption of advanced diagnostics, biologics, and preventative care, rendering the UAE a premium market for equine therapeutics.

Factors Driving Market Growth

• Robust Horse Racing & Endurance Sector: The UAE's global-leading horse racing competitions (e.g., Dubai World Cup), along with other high-endurance rides, create a demand for sophisticated equine medical care, injury management, and performance-enhancing therapies.
• Elite Equine Facilities & Expertise: Restaurants for racehorses & endurance horses; top-notch orthopedic surgery, physiotherapy, and preventative care
• Widespread Use of Biologics & Regenerative Therapies: Adoption of PRP, stem cell therapy, and gene therapy helps joint repair, increases recovery times, and improves performance for the high-value sport and racing horses in the UAE.
• Government Support & Regulations: Strict veterinary regulations require frequent equine vaccinations, illness detection, and welfare rules to guarantee top-notch veterinary care and preventative treatment for them in racing, breeding, and endurance sports.
• Significant Owners Buying Power: Affluent race horse and endurance horse owners are renowned for their high investment in quality veterinary healthcare solutions, such as custom treatment plans, luxury supplements, and pioneering therapies ensuring peak equine performance

Market Forecast

Year	CAGR (2025 to 2035)
2025 to 2035	5.1%

Saudi Arabia

Market Outlook

Royal patronage, high-volume investments in equestrian sports, and a budding breeding industry characterize the Saudi Arabian Veterinary Vaccines market, which is poised for accelerated growth. The Kingdom is home to prominent horse racing and show-jumping events such as the Saudi Cup, which has helped grow the demand for lameness treatments, regenerative therapies and specialty veterinary care.

An expansion in veterinary infrastructure, government support for equine welfare, and an increasing number of private equestrian centers drive sustained growth in the market. Well, good quality equine healthcare services, such as the adoption of biologics, NSAIDs, and advanced diagnostic tools, continue to be key contributors to services.

Factors Driving Market Growth

• Leading Horse Racing & Equestrian Events: The flagship Saudi Cup and elite show-jumping and endurance competitions are creating high demand for advanced veterinary care, injury prevention and performance-enhancing treatments.
• Increasing Equine Breeding & Training Capabilities: Expansion of royal-backed breeding programs coupled with an increase in the number of private training facilities requires specialized veterinary care, genetic testing, reproductive health management, and foal disease prevention strategies.
• On the ground investment in modern veterinary facilities: Despite Saudi Arabia currently lacking a stable demand for advanced equine treatment, the Kingdom is investing heavily in modern equine hospitals, diagnostic laboratories and research facilities that will provide ready access to the latest treatments, whether orthopedic surgery, regenerative therapies or preventive healthcare.
• Government-Supported Equine Welfare Initiatives: These include strict veterinary regulations, disease surveillance programs, and equine welfare policies to ensure that horses in racing, breeding, and sport receive high-quality healthcare and preventive treatments.
• Increasing Acceptance of Advanced Therapies: Rising application of PRP, stem cell therapy, biologics, and gene therapy enables faster recovery, better joint health, and prolongs the life of high-value sport and racehorses.

Market Forecast

Year	CAGR (2025 to 2035)
2025 to 2035	4.9%

Türkiye

Market Outlook

Türkiye’s Developing Veterinary Vaccines Market-Horse Racing Industry, Equestrian Culture, and Government-Supported Breeding Programs. The country’s expansive racing sector, spearheaded by the Jockey Club of Turkey, also drives demand for joint health solutions, anti-inflammatory drugs and lameness therapies.

Improvements in diagnostics, surgical techniques, and regenerative medicine are also enhancing treatment outcomes. Increasing horse ownership, as well as a significant rise in recreational riding trends, are further fueling growth in the market, along with growing investments in developing effective equine health solutions.

Factors Driving Market Growth

• Robust Horse Racing Sector: Türkiye’s Jockey Club manages a burgeoning racing industry, which translates into higher demand for equine therapeutics, including joint health products, anti-inflammatory medications, and regenerative medicine for performance horses.
• Government-Sponsored Breeding Programs: National breeding programs, aimed at the genetic improvement and disease control, as well as health checks, enable Türkiye's horses to achieve higher reproductive efficiency and thus, improved health more generally.
• Increased Use of Regenerative Medicine: The use of regenerative medicine, such as PRP and stem cell therapy, for the treatment of lameness, osteoarthritis and tendon injuries in performance and racehorses is also on the rise, improving injury recovery rates and prolonging the careers of sport and racehorses.
• Modern Veterinary Clinics & Research Facilities: Investment in state-of-the-art equine hospitals and research centers improves diagnostic capabilities, surgical outcomes, and therapeutic development, catering to the needs of Türkiye’s expanding equestrian sector
• Growing Interest in Equestrian Sports and Leisure Riding: Increased horse ownership for leisure, competition, and tourism drives demand for preventive veterinary care, vaccines, deworming programs, and GCCs.

Market Forecast

Year	CAGR (2025 to 2035)
2025 to 2035	3.8%

Jordan

Market Outlook

Jordan’s Veterinary Vaccines market is profiting from a longstanding Arabian horse breeding tradition and growing equestrian tourism, and it is underpinned by support from royalty for the industry. Regional events for endurance riding and show-jumping are also held in the country, creating a need for joint care, pain management and preventive healthcare.

Investment in veterinarian education, specialty clinics, and equine welfare initiatives are helping to increase access to advanced treatments. Rising demands for biologics, NSAIDs and vaccines are driven by greater awareness of equine health management.

Factors Driving Market Growth

• Arabian Horse Breeding & Heritage: A large portion of the story is the Arabian horse, generated out of Jordan's strong Arabian horse breeding sector, with a need for high-quality veterinary care, fertility and bespoke disease prevention systems.
• Expanding Equestrian Sports & Tourism: The increase in attendance in endurance racing, show jumping, and recreational riding boosts the need for innovative equine therapies, injury management solutions, and performance boosting veterinary solutions.
• Development of Veterinary Training & Facilities: The number of veterinary programs targeted at equine practice has increased, as have modern clinics where skilled professionals provide accurate diagnostic, surgical, and preventative healthcare services to Jordan’s horses.
• Growing Demand for Lameness and Pain Management Therapies: This would include an increase in cases of osteoarthritis and tendon injuries that would drive the adoption of NSAIDs, corticosteroids, PRP and stem cell therapy to relieve pain and repair joints.
• Government & Private Sector Investments in Equine Health: Policy-enabled welfare measures and private funding in veterinary infrastructure augment standards of care, enabling adoption of quality therapeutics and specialized treatment plan.

Market Forecast

Year	CAGR (2025 to 2035)
2025 to 2035	3.7%

Sudan

Market Outlook

The Sudan Veterinary Vaccines market is stimulated by the role of horses in agriculture, transport and traditional sports, but not racing or recreation. The high demand for vaccines, antiparasitic treatments, and anti-inflammatory drugs is attributed to the widespread prevalence of infectious diseases and harsh climatic conditions.

Challenges include limited access to specialized equine health-care infrastructure and veterinary expertise, but international aid and veterinary training programs are enhancing the market. Ongoing efforts to improve disease control and preventive care are slowly strengthening the nation’s equine health infrastructure.

Factors Driving Market Growth

• Horses are extensively used in Agriculture & Transport: In rural Sudan, horses are still essential for agriculture and transport, which in turn, contributes to the need for veterinary care, nutritional assistance, and preventive care solutions.
• High Prevalence of Infectious Diseases: Within Sudan’s equine sector, endemic diseases, including equine piroplasmosis, African horse sickness, and tetanus, create significant demand for vaccines, diagnostic tools, and effective disease management strategies.
• Partnership on Veterinary Training & International Aid: Educators work with local entities to increase veterinary capacity, veterinarians work to support equine welfare & access to essential veterinary care where it is lacking.
• High Demand for Anti-Parasitic and Anti-Inflammatory Therapies: The unfavorable environmental conditions result in high parasite infestations and lameness, thus leading to high demand for de-worming treatments, NSAIDs as well as regenerative therapies for working horses.
• Equine Disease Surveillance & Control Initiatives: Government and NGOs are working to contain diseases through surveillance, vaccination, and access to treatment in Sudan.

Market Forecast

Year	CAGR (2025 to 2035)
2025 to 2035	2.7%

Competitive Outlook

The Middle East veterinary vaccine market is rapidly progressing due to the growing concern about animal health, investments to enhance production in livestock, and initiatives undertaken by governments to control zoonotic diseases. There is an increase in demand for vaccines among companion animals and livestock for the prevention of foot and mouth disease, avian influenza, rabies and infectious diseases.

Key players in the market, alongside multinational animal health companies currently ramping up their regional presence through strategic alliances, acquisitions, and launches of novel vaccines, are serious contenders entrenching local producers on the ground with government support in terms of subsidies, research grants, and regulatory assistance to boost domestic production capacity.

Other Key Players

Additional companies supporting the Middle East veterinary vaccine market include:

• Vaxxinova
• Biovet JSC
• Indian Immunologicals Ltd.
• Elanco Animal Health
• HIPRA

Report Scope Table - Middle East Veterinary Vaccine Market

Report Attributes	Details
Current Total Market Size (2025)	USD 678.3 million
Projected Market Size (2035)	USD 1,053.3 million
CAGR (2025 to 2035)	4.0%
Base Year for Estimation	2024
Historical Period	2020 to 2024
Projections Period	2025 to 2035
Quantitative Units	USD million for value and thousand doses for volume
Vaccines Analyzed (Segment 1)	Attenuated Live Vaccines, Inactivated Vaccines, Toxoid Vaccines, DNA Vaccines, Recombinant Vaccines, Others
Animal Types Analyzed (Segment 2)	Companion Animals, Livestock Animals, Equine
Disease Indications Analyzed (Segment 3)	Foot and Mouth Disease, Newcastle Disease, PPRS, Canine Parvovirus, Brucellosis, Avian Influenza, Others
End Users Analyzed (Segment 4)	Hospital Pharmacies, Veterinary Clinics, Private Veterinary Pharmacies, Others
Regions Covered	Middle East
Countries Covered	Saudi Arabia, UAE, Qatar, Kuwait, Oman, Bahrain, Jordan, Israel, Egypt, Lebanon
Key Players influencing the Middle East Veterinary Vaccine Market	Zoetis Inc., Merck Animal Health, Boehringer Ingelheim, Ceva Santé Animale, Jordan Bio-Industries Center (JOVAC), Vaxxinova, Biovet JSC, Indian Immunologicals Ltd., Elanco Animal Health, HIPRA
Additional Attributes	Share of live vs recombinant vaccine usage, Vaccination trends in poultry and ruminants, Government procurement and immunization campaign strategies, Emerging threats from zoonotic and endemic diseases in the region, Role of private veterinary clinics in vaccine distribution
Customization and Pricing	Customization and Pricing Available on Request

Key Segments 

By Vaccine:

Attenuated Live Vaccines, Inactivated Vaccines, Toxoid Vaccines, DNA Vaccines, Recombinant Vaccines and Others.

By Animal Type:

Companion Animals, Livestock Animals and Equine.

By Disease Indication:

Foot and Mouth Disease, Newcastle Disease, PPRS, Canine Parvovirus, Brucellosis, Avian Influenza and Others.

By End User:

Hospital Pharmacies, Veterinary Clinics, Private Veterinary Pharmacies and Others.

By Country:

United Arab Emirates, Saudi Arabia, Türkiye, Jordan, Sudan, Egypt and Rest of Middle East.